Farther Finance Advisors, LLC Cullinan Oncology, Inc. Transaction History
Farther Finance Advisors, LLC
- $5 Trillion
- Q2 2025
A detailed history of Farther Finance Advisors, LLC transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 1,365 shares of CGEM stock, worth $11,370. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,365
Previous 1,013
34.75%
Holding current value
$11,370
Previous $7.6 Million
35.27%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CGEM
# of Institutions
155Shares Held
68.5MCall Options Held
15.6KPut Options Held
17.9K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$63.7 Million10.72% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$47.9 Million1.91% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.86MShares$32.2 Million0.74% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$29.6 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$28.4 Million15.23% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $380M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...